Cargando…
Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure
Early initiation of antiretroviral therapy (ART) significantly improves clinical outcomes and reduces mortality of infants/children living with HIV. However, the ability of infected cells to establish latent viral reservoirs shortly after infection and to persist during long-term ART remains a major...
Autores principales: | Berendam, Stella J., Nelson, Ashley N., Yagnik, Bhrugu, Goswami, Ria, Styles, Tiffany M., Neja, Margaret A., Phan, Caroline T., Dankwa, Sedem, Byrd, Alliyah U., Garrido, Carolina, Amara, Rama R., Chahroudi, Ann, Permar, Sallie R., Fouda, Genevieve G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325996/ https://www.ncbi.nlm.nih.gov/pubmed/35911681 http://dx.doi.org/10.3389/fimmu.2022.885272 |
Ejemplares similares
-
Harnessing early life immunity to develop a pediatric HIV vaccine that can protect through adolescence
por: Goswami, Ria, et al.
Publicado: (2020) -
Understanding Early-Life Adaptive Immunity to Guide Interventions for Pediatric Health
por: Semmes, Eleanor C., et al.
Publicado: (2021) -
Assessing the impact of autologous neutralizing antibodies on viral rebound in postnatally SHIV-infected ART-treated infant rhesus macaques
por: Mainou, Ellie, et al.
Publicado: (2023) -
Maternal Fc-mediated non-neutralizing antibody responses correlate with protection against congenital human cytomegalovirus infection
por: Semmes, Eleanor C., et al.
Publicado: (2022) -
Simian-Human Immunodeficiency Virus SHIV.C.CH505 Persistence in ART-Suppressed Infant Macaques Is Characterized by Elevated SHIV RNA in the Gut and a High Abundance of Intact SHIV DNA in Naive CD4(+) T Cells
por: Obregon-Perko, Veronica, et al.
Publicado: (2020)